Mirjam Schenk’s research group at the Institute of Pathology, University of Bern (from left to right: Mirjam Schenk, Steve Robatel, Lukas Bäriswyl, Mirela Kremenovic). Image: Mirjam Schenk
Mirjam Schenk's research group at the Institute of Pathology, University of Bern (from left to right: Mirjam Schenk, Steve Robatel, Lukas Bäriswyl, Mirela Kremenovic). Image: Mirjam Schenk - Researchers at the University of Bern have developed a therapy option that activates the body's own defense system against black skin cancer. Components of a bacterium are embedded in gel and applied directly to the area of the tumor. In the model, the gel was shown to reduce tumor growth, inhibit its spread to other organs and thereby prolong survival. In a next step, the gel will be tested for its efficacy in patients in clinical trials. Black skin cancer (melanoma) is a malignant cancer that can be completely removed with good chances of cure if diagnosed early. However, the prospects worsen for those affected if, in later stages of the disease, offshoots (metastases) of the tumor already spread to other organs.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
